High-Dose Chemotherapy with Bendamustin and Melphalan Improves the Rate of Complete Remission in Myeloma Patients in First Remission Compared to Standard Melphalan Alone

被引：0
|
作者：
Farag, Sarah
Bacher, Ulrike
Legros, Myriam
Betticher, Daniel
Luthi, Jean-Marc
Egger, Thomas
Zander, Thilo
Jeker, Barbara
Pabst, Thomas
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141545
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] RETRACTED: Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration (Retracted Article)
    Ge, Qunfang
    Wang, Yi
    Zhu, Huiling
    Xu, Kaihong
    Sheng, Lixia
    Yan, Xiaoyan
    Ouyang, Guifang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [42] Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan
    Masaharu Tamaki
    Hideki Nakasone
    Ayumi Gomyo
    Jin Hayakawa
    Yu Akahoshi
    Naonori Harada
    Machiko Kusuda
    Yuko Ishihara
    Koji Kawamura
    Aki Tanihara
    Miki Sato
    Kiriko Terasako-Saito
    Kazuaki Kameda
    Hidenori Wada
    Misato Kikuchi
    Shun-ichi Kimura
    Shinichi Kako
    Yoshinobu Kanda
    International Journal of Hematology, 2018, 108 : 423 - 431
  • [43] Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan
    Tamaki, Masaharu
    Nakasone, Hideki
    Gomyo, Ayumi
    Hayakawa, Jin
    Akahoshi, Yu
    Harada, Naonori
    Kusuda, Machiko
    Ishihara, Yuko
    Kawamura, Koji
    Tanihara, Aki
    Sato, Miki
    Terasako-Saito, Kiriko
    Kameda, Kazuaki
    Wada, Hidenori
    Kikuchi, Misato
    Kimura, Shun-ichi
    Kako, Shinichi
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (04) : 423 - 431
  • [44] Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis
    J. Hillengass
    A. D. Ho
    H. Goldschmidt
    R. Waldherr
    T. M. Moehler
    International Journal of Hematology, 2008, 88 : 454 - 456
  • [45] Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis
    Hillengass, J.
    Ho, A. D.
    Goldschmidt, H.
    Waldherr, R.
    Moehler, T. M.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (04) : 454 - 456
  • [46] Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma
    Wiesmann, A
    Einsele, H
    Kanz, L
    Dohmen, BM
    BONE MARROW TRANSPLANTATION, 2005, 36 (01) : 89 - 90
  • [47] Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma
    A Wiesmann
    H Einsele
    L Kanz
    B M Dohmen
    Bone Marrow Transplantation, 2005, 36 : 89 - 90
  • [48] NAD plus metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma
    Soncini, Debora
    Becherini, Pamela
    Ladisa, Francesco
    Ravera, Silvia
    Chedere, Adithya
    Gelli, Elisa
    Giorgetti, Giulia
    Martinuzzi, Claudia
    Piacente, Francesco
    Mastracci, Luca
    Veneziano, Claudia
    Santamaria, Gianluca
    Monacelli, Fiammetta
    Ghanem, Moustafa S.
    Cagnetta, Antonia
    Guolo, Fabio
    Garibotto, Matteo
    Aquino, Sara
    Passalaqua, Mario
    Bruzzone, Santina
    Bellotti, Axel
    Duchosal, Michel A.
    Nahimana, Aimable
    Angelucci, Emanuele
    Nagasuma, Chandra
    Nencioni, Alessio
    Lemoli, Roberto Massimo
    Cea, Michele
    BLOOD ADVANCES, 2025, 9 (05) : 1024 - 1039
  • [49] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
  • [50] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
12345